Brief: Scancell Holdings Reports Strong Phase 2 Data On iSCIB1+ In Melanoma

Scancell Holdings

22/07/2025 07:44

July 22 (Reuters) - Scancell Holdings PLC SCLP.L:

SCANCELL HOLDINGS PLC: STRONG PHASE 2 DATA ON ISCIB1+ IN MELANOMA

SCANCELL HOLDINGS PLC - ISCIB1+ SHOWS 69% RESPONSE RATE, EXCEEDS STANDARD CARE

Source text: ID:nRSV9482Ra

Further company coverage: SCLP.L

 ((Reuters.Briefs@thomsonreuters.com))